Dipalo Ventures is a Chicago-based early-stage venture capital firm investing in breakthrough innovations leveraging hard tech, software, and AI. They focus on supporting hard tech innovators and scaling life-changing technologies for a green energy future, providing product expertise and deep engineering knowledge.

Hikma Ventures is the strategic venture capital arm of Hikma Pharmaceuticals, investing in innovative digital health and life sciences companies worldwide. They invest in disruptive technologies and meaningful companies with a diverse leadership team. Their investment mandate is broad, focusing on areas where they see strategic advantages for both Hikma and their portfolio companies.

Wildcat Venture Partners invests in B2B and B2B2C startups leveraging AI and Machine Learning to disrupt healthcare and energy transition sectors. They focus on helping entrepreneurs 'Cross the Chasm' to scale, offering a capital-efficient playbook and strong network of partners and advisors.

TFX Capital is a small venture firm exclusively focused on supporting ex-military and ex-national security founders. They invest in early-stage technology solutions that strengthen national security and healthcare. Their investment strategy emphasizes a network-driven approach to accelerate founder success.

Flare Capital Partners provides capital for early-stage and emerging healthcare technology companies.

High Alpha is a venture firm that creates and funds B2B SaaS companies. They partner with founders to build businesses and reach their full potential, focusing on enterprise software and various related technology sectors.

KPN Ventures invests in European technology companies. They partner with innovative companies, providing access to capital, expertise, network, and customer channels.

Spider Capital is a seed-stage venture capital firm solely focused on backing next-generation enterprise cloud software companies. They leverage their extensive enterprise operating experience and network to provide significant value to their portfolio companies.

Target Global is passionate about empowering growth by investing in transformational technology. We support the boldest and bravest entrepreneurs in making a positive impact on the world.

Playground Global is an early-stage deep tech venture capital firm investing in technical founders. They help build companies at the earliest stages, leveraging their engineering expertise and commitment to founders taking scientific and technological risks.

V-Bio Ventures is a life science Venture Capital fund that co-creates startups and invests in early- to mid-stage companies with high growth potential in therapeutics. They leverage great science and empower talented entrepreneurs to transform scientific innovation into impactful products. V-Bio aims to be an integral part of the new ventures they support.

HCVC is a thesis-driven venture capital firm that backs founders on a mission to industrialize technological progress. They invest in hardtech companies from inception to Series A, with a focus on breakthrough technologies across Europe and the US.